Rosetta Genomics (ROSG) shares continue their helium-like rise, +15.2% premarket after...

|About: Rosetta Genomics Ltd. (ROSG)|By:, SA News Editor

Rosetta Genomics (ROSG) shares continue their helium-like rise, +15.2% premarket after yesterday's +51% jump on no apparent news. Shares have climbed seven-fold since the May 16 news that Novitas, the designated Medicare Administrative Contractor for ROSG's miRview mets2 assay, plans to cover the assay for all Medicare beneficiaries.